COMPOSITION CONTAINING PURIFIED EXTRACT, EXTRACTED FROM Pseudolysimachion rotundum var.subintegrum CONTAINING GREAT AMOUNT OF ACTIVE COMPONENT,OR COMPOUNDS, EXTRACTED FROM IT, AS ACTIVE COMPONENT FOR PROPHYLAXIS OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND THEREOF
LI Ennam (KR),ЛИ Ённам (KR),YU CHi-sok (KR),Ю Чи-сок (KR),SIN Te-khi (KR),СИН Тэ-хи (KR),LYU Pen-khvan (KR),ЛЮ Пён-хван (KR),AN Ken Sop (KR),АН Кён Соп (KR),O Se Lyan (KR),О Се Лян (KR),LI KHen Ke (KR,LI Ennam,ЛИ Ённам,YU CHi-sok,Ю Чи-сок,SIN Te-khi,СИН Тэ-хи,LYU Pen-khvan,ЛЮ Пён-хван,AN Ken Sop,АН Кён Соп,O Se Lyan,О Се Лян,LI KHen Ke,ЛИ Хён Кё,SIN In Sik,СИН Ин Сик,KIM Du En,КИМ Ду Ён,KVON Ok-Ken
申请号：
RU2015138441/15
公开号：
RU0002594061C1
申请日:
2014.04.09
申请国别(地区):
RU
年份:
2016
代理人:
摘要：
FIELD: pharmaceutics.SUBSTANCE: pharmaceutical composition containing an extract of Pseudolysimachion rotundum var. subintegrum, purified by means of secondary fractionation (ATS2) containing verproside, veratric acid, catalposide, picroside II, isovanilloyl catalpol and 6-O-veratroyl catalpol or verproside in a certain amount for treating or preventing chronic obstructive pulmonary disease (COPD) (versions). Pharmaceutical composition contains a combination of verproside, veratric acid, catalposide, picroside II, isovanilloyl catalpol, 6-O-veratroyl catalpol, and pharmaceutically acceptable carriers or excipients for treating or preventing chronic obstructive pulmonary disease (COPD). Functional food product useful for health contains an extract of Pseudolysimachion rotundum var. subintegrum, purified by means of secondary fractionation (ATS2) containing verproside, veratric acid, catalposide, picroside II, isovanilloyl catalpol, 6-O-veratroyl catalpol or verproside, as an active ingredient, taken in certain proportions, for relief or prevention of chronic obstructive pulmonary disease (COPD). Functional food product useful for health contains a combination of said compounds, in certain proportions, for relief or prevention of chronic obstructive pulmonary disease (COPD).EFFECT: agents described above effective for treating or preventing chronic obstructive pulmonary disease.6 cl, 24 dwg, 5 tbl, 6 exНастоящее изобретение относится к фармацевтической промышленности, а именно к композиции для лечения или профилактики хронической обструктивной болезни легких (ХОБЛ). Фармацевтическая композиция, содержащая экстракт Pseudolysimachion rotundum var. subintegrum, очищенный с помощью вторичного фракционирования (АТС2), содержащий верпрозид, вератровую кислоту, каталпозид, пикрозид II, изованиллоил каталпол и 6-О-вератроил каталпол или верпрозид, в определенном количестве, для лечения или профилактики хронической обструктивной болезни легких (ХОБЛ) (варианты). Фармацевтиче
